XML 38 R22.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Organization and Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Sep. 30, 2022
Accounting Policies [Abstract] |
Schedule of Company's Current Pipeline | The following table presents the Company’s current pipeline:
Therapeutic Area | Name | Stage | Product Rights
Cardiometabolic | ARO-APOC3 | Two Phase 2b and one Phase 3 | Arrowhead
| ARO-ANG3 | Two Phase 2b | Arrowhead
| Olpasiran | Phase 3 | Amgen
Pulmonary | ARO-ENAC2 | Pre-Clinical | Arrowhead
| ARO-RAGE | Phase 1/2 | Arrowhead
| ARO-MUC5AC | Phase 1/2a | Arrowhead
| ARO-MMP7 | Phase 1/2 | Arrowhead
Liver | ARO-HSD | Phase 1/2 | GSK
| ARO-AAT | Phase 2 | Takeda and Arrowhead
| JNJ-3989 | Phase 2 | Janssen
| ARO-XDH | Phase 1 | Horizon
| ARO-C3 | Phase 1/2 | Arrowhead
| JNJ-75220795 | Phase 1 | Janssen
Muscle | ARO-DUX4 | Pre-Clinical | Arrowhead

X
- Definition Schedule of Current Products + References No definition available. + Details
Name: | arwr_ScheduleOfCurrentProductsTableTextBlock
Namespace Prefix: | arwr_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration